Matching patient populations with a targetable genomic alteration to a specific investigational study is the aim of a new clinical trial through OneR and Genentech. This partnership will facilitate collaborations on various clinical trials, scientific research and real-world data studies that will advance personalized cancer care at community oncology centers like West.

“With too many of our patients disproportionately impacted by health disparities, we believe that by providing community oncology practices with enhanced operational efficiencies we can ensure that more patients will benefit from the groundbreaking clinical trials,” said Axel Grothey, MD, Medical Director, OneR and Director, GI Cancer Research, West Cancer Center. “OneR will not only improve patient access to cutting-edge care, it will also help to advance scientific discovery.”

Click here to learn more.